ONS guidelines™ for cancer treatment-related lymphedema

Jane M. Armer; Pamela L. Ostby; Pamela K. Ginex; Marcia Beck; Jie Deng; Mei R. Fu; Bonnie B. Lasinski; Suzy Lockwood; Ellen Poage; Joan White; Christine Maloney; Kerri A. Moriarty; Mark Vrabel; Rebecca L. Morgan

doi:10.1188/20.ONF.518-538

ONS guidelines™ for cancer treatment-related lymphedema

Jane M. Armer, Pamela L. Ostby, Pamela K. Ginex, Marcia Beck, Jie Deng, Mei R. Fu, Bonnie B. Lasinski, Suzy Lockwood, Ellen Poage, Joan White, Christine Maloney, Kerri A. Moriarty, Mark Vrabel, Rebecca L. Morgan

Research output: Contribution to journal › Review article › peer-review

Abstract

PURPOSE: Lymphedema is a chronic condition that may result from cancer-related surgery. The incidence of lymphedema varies greatly; however, patients remain at risk for life and may experience decreased quality of life and functional capacity. Providing recommendations for an evidence-based guideline for care of cancer treatment-related lymphedema will help to improve outcomes for patients with this chronic condition. METHODOLOGIC APPROACH: A panel of healthcare professionals with patient representation convened to develop a national clinical practice guideline on prospective surveillance, risk reduction, and conservative treatment of lymphedema. Systematic reviews of the literature were conducted and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology approach was used to assess the evidence. FINDINGS: The panel made multiple recommendations for patients who are at risk for or experiencing lymphedema. IMPLICATIONS FOR NURSING: Early diagnosis and treatment of lymphedema may mitigate symptoms. This evidence-based guideline supports patients, clinicians, and other healthcare professionals in clinical decision making.

Original language	English (US)
Pages (from-to)	518-538
Number of pages	21
Journal	Oncology nursing forum
Volume	47
Issue number	5
DOIs	https://doi.org/10.1188/20.ONF.518-538
State	Published - 2020

Keywords

GRADE
Guideline development
Lymphedema
Prospective surveillance
Systematic review
Prospective Studies
Risk Reduction Behavior
Humans
Lymphedema/etiology
Quality of Life
Neoplasms/complications

ASJC Scopus subject areas

Oncology(nursing)

Access to Document

10.1188/20.ONF.518-538

Cite this

@article{a10ce3c6eb1c40f3bfad13cf8087da6c,

title = "ONS guidelines{\texttrademark} for cancer treatment-related lymphedema",

abstract = "PURPOSE: Lymphedema is a chronic condition that may result from cancer-related surgery. The incidence of lymphedema varies greatly; however, patients remain at risk for life and may experience decreased quality of life and functional capacity. Providing recommendations for an evidence-based guideline for care of cancer treatment-related lymphedema will help to improve outcomes for patients with this chronic condition. METHODOLOGIC APPROACH: A panel of healthcare professionals with patient representation convened to develop a national clinical practice guideline on prospective surveillance, risk reduction, and conservative treatment of lymphedema. Systematic reviews of the literature were conducted and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology approach was used to assess the evidence. FINDINGS: The panel made multiple recommendations for patients who are at risk for or experiencing lymphedema. IMPLICATIONS FOR NURSING: Early diagnosis and treatment of lymphedema may mitigate symptoms. This evidence-based guideline supports patients, clinicians, and other healthcare professionals in clinical decision making.",

keywords = "GRADE, Guideline development, Lymphedema, Prospective surveillance, Systematic review, Prospective Studies, Risk Reduction Behavior, Humans, Lymphedema/etiology, Quality of Life, Neoplasms/complications",

author = "Armer, {Jane M.} and Ostby, {Pamela L.} and Ginex, {Pamela K.} and Marcia Beck and Jie Deng and Fu, {Mei R.} and Lasinski, {Bonnie B.} and Suzy Lockwood and Ellen Poage and Joan White and Christine Maloney and Moriarty, {Kerri A.} and Mark Vrabel and Morgan, {Rebecca L.}",

year = "2020",

doi = "10.1188/20.ONF.518-538",

language = "English (US)",

volume = "47",

pages = "518--538",

journal = "Oncology nursing forum",

issn = "0190-535X",

publisher = "Oncology Nursing Society",

number = "5",

}

TY - JOUR

T1 - ONS guidelines™ for cancer treatment-related lymphedema

AU - Armer, Jane M.

AU - Ostby, Pamela L.

AU - Ginex, Pamela K.

AU - Beck, Marcia

AU - Deng, Jie

AU - Fu, Mei R.

AU - Lasinski, Bonnie B.

AU - Lockwood, Suzy

AU - Poage, Ellen

AU - White, Joan

AU - Maloney, Christine

AU - Moriarty, Kerri A.

AU - Vrabel, Mark

AU - Morgan, Rebecca L.

PY - 2020

Y1 - 2020

N2 - PURPOSE: Lymphedema is a chronic condition that may result from cancer-related surgery. The incidence of lymphedema varies greatly; however, patients remain at risk for life and may experience decreased quality of life and functional capacity. Providing recommendations for an evidence-based guideline for care of cancer treatment-related lymphedema will help to improve outcomes for patients with this chronic condition. METHODOLOGIC APPROACH: A panel of healthcare professionals with patient representation convened to develop a national clinical practice guideline on prospective surveillance, risk reduction, and conservative treatment of lymphedema. Systematic reviews of the literature were conducted and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology approach was used to assess the evidence. FINDINGS: The panel made multiple recommendations for patients who are at risk for or experiencing lymphedema. IMPLICATIONS FOR NURSING: Early diagnosis and treatment of lymphedema may mitigate symptoms. This evidence-based guideline supports patients, clinicians, and other healthcare professionals in clinical decision making.

AB - PURPOSE: Lymphedema is a chronic condition that may result from cancer-related surgery. The incidence of lymphedema varies greatly; however, patients remain at risk for life and may experience decreased quality of life and functional capacity. Providing recommendations for an evidence-based guideline for care of cancer treatment-related lymphedema will help to improve outcomes for patients with this chronic condition. METHODOLOGIC APPROACH: A panel of healthcare professionals with patient representation convened to develop a national clinical practice guideline on prospective surveillance, risk reduction, and conservative treatment of lymphedema. Systematic reviews of the literature were conducted and the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology approach was used to assess the evidence. FINDINGS: The panel made multiple recommendations for patients who are at risk for or experiencing lymphedema. IMPLICATIONS FOR NURSING: Early diagnosis and treatment of lymphedema may mitigate symptoms. This evidence-based guideline supports patients, clinicians, and other healthcare professionals in clinical decision making.

KW - GRADE

KW - Guideline development

KW - Lymphedema

KW - Prospective surveillance

KW - Systematic review

KW - Prospective Studies

KW - Risk Reduction Behavior

KW - Humans

KW - Lymphedema/etiology

KW - Quality of Life

KW - Neoplasms/complications

UR - http://www.scopus.com/inward/record.url?scp=85089793886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089793886&partnerID=8YFLogxK

U2 - 10.1188/20.ONF.518-538

DO - 10.1188/20.ONF.518-538

M3 - Review article

C2 - 32830794

AN - SCOPUS:85089793886

SN - 0190-535X

VL - 47

SP - 518

EP - 538

JO - Oncology nursing forum

JF - Oncology nursing forum

IS - 5

ER -

ONS guidelines™ for cancer treatment-related lymphedema

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this